References
- PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet2004364943461362015313363
- QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
- VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
- HoggJCPathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet2004364943570972115325838
- BakkePSRonmarkEEaganTRecommendations for epidemiological studies on COPDEur Respir J20113861261127722130763
- EnrightPBrusascoVCounterpoint: should we abandon FEV(1)/FVC <0.70 to detect airway obstruction? YesChest2010138510401042 discussion 1042–104421051394
- CelliBRHalbertRJPoint: should we abandon FEV(1)/FVC <0.70 to detect airway obstruction? NoChest201013851037104021051393
- Chronic Obstructive Pulmonary DiseaseNational clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary careThorax200459suppl 11232
- TunksMMillerDCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease–2008 update–highlights for primary careCan Respir J2008154219 author reply 219
- National Clinical Guideline C. National Institute for Health and Clinical Excellence: guidanceChronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary CareLondonRoyal College of Physicians (UK) National Clinical Guideline Centre – Acute and Chronic Conditions201022673 Available from: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0033903/Access date February 13, 2018
- SwanneyMPRuppelGEnrightPLUsing the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstructionThorax200863121046105118786983
- RobertsSDFarberMOKnoxKSFEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of ageChest2006130120020616840402
- HardieJABuistASVollmerWMEllingsenIBakkePSMorkveORisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163
- BrusascoVSpirometric definition of COPD: exercise in futility or factual debate?Thorax201267756957022467708
- ManninoDMSonia BuistAVollmerWMChronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?Thorax200762323724117090573
- ManninoDMDiaz-GuzmanEInterpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortalityChest20121411738021659434
- CerveriICorsicoAGAccordiniSUnderestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomesThorax200863121040104518492741
- Garcia-RioFSorianoJBMiravitllesMOverdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of lifeChest201113951072108021183609
- GuderGBrennerSAngermannCEGOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-studyRespir Res20121311322309369
- AkkermansRPBerrevoetsMASmeeleIJLung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjectsBMC Pulm Med2012121222439763
- van DijkWDGuptaNTanWCBourbeauJClinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic reviewCOPD201411111312023862613
- GlaabTVogelmeierCBuhlROutcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitationsRespir Res2010117920565728
- LeeSWKimHKBaekSDevelopment of a spirometry T-score in the general populationInt J Chron Obstruct Pulmon Dis20161136937926966359
- HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general U.S. populationAm J Respir Crit Care Med199915911791879872837
- StanojevicSWadeAStocksJReference ranges for spirometry across all ages: a new approachAm J Respir Crit Care Med2008177325326018006882
- Vaz FragosoCAConcatoJMcAvayGThe ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181544645120019341
- QuanjerPHStanojevicSColeTJMulti-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
- SuissaSEffectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studiesAm J Respir Crit Care Med20031681495312663327
- SuissaSBarnesPJInhaled corticosteroids in COPD: the case againstEur Respir J2009341131619567599
- SorianoJBManninoDMReversing concepts on COPD irreversibilityEur Respir J200831469569618378779
- Global Lung Function Initiative Available from: http://www.ers-education.org/guidelines/global-lung-function-initiative.aspxAccessed February 08, 2018